[144] VTEX SEC Filing
A VTEX shareholder filed a Form 144 notice indicating an intent to sell up to 9,616 shares of common stock, with an aggregate market value of $38,560.16. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, and the filing notes that 103,947,244 common shares are outstanding. The seller acquired these 9,616 shares as founder shares from the issuer on 10/25/2021.
The notice also lists prior sales over the last three months under a Rule 10b5-1 trading program for MIRA LIMITED, including one transaction of 4,808 common shares on 11/10/2025 for $19,236.81. By signing the form, the seller represents that they are not aware of any undisclosed material adverse information about VTEX’s current or prospective operations.
- None.
- None.
FAQ
What does the VTEX Form 144 filing disclose?
The filing discloses that a VTEX shareholder plans to sell up to 9,616 shares of common stock, with an aggregate market value of $38,560.16, through Morgan Stanley Smith Barney LLC on the NYSE.
How many VTEX shares are outstanding according to this Form 144?
The notice states that there are 103,947,244 common shares outstanding for VTEX at the time referenced in the filing.
How and when were the 9,616 VTEX shares being sold acquired?
The 9,616 shares covered by this notice were acquired as founder shares from the issuer on 10/25/2021, with the same date listed for payment.
What prior VTEX share sales by the same holder are reported in the last 3 months?
The filing lists multiple prior sales under a Rule 10b5-1 plan for MIRA LIMITED, including a sale of 4,808 common shares on 11/10/2025 for $19,236.81, along with other similar-sized trades in recent weeks.
What is the role of Morgan Stanley Smith Barney LLC in this VTEX Form 144?
Morgan Stanley Smith Barney LLC is identified as the broker handling the proposed sale of the 9,616 VTEX common shares on the NYSE.
What representation does the VTEX shareholder make by signing Form 144?
By signing, the shareholder represents that they do not know of any material adverse information about VTEX’s current or prospective operations that has not been publicly disclosed.
What is the significance of Rule 10b5-1 in this VTEX Form 144 filing?
The filing references 10b5-1 sales for MIRA LIMITED, indicating that some VTEX share sales have been made under a pre-arranged trading plan designed to comply with Rule 10b5-1 under the Exchange Act.